CCS
CDMO

Crosspoint Capital Strategies’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Crosspoint Capital Strategies’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-14
Closed – – 858
2015
Q4 		$0 Buy
+14
New +$113 ﹤0.01% 1226

Other funds holding CDMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 28.54% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Crosspoint Capital Strategies's CDMO Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2016, closing a stake of 14 shares.

Crosspoint Capital Strategies first reported a position in CDMO in Q4 2015 and held it in 1 quarter. The position peaked at $0 in Q4 2015. 84 funds tracked by Wall St. Rank hold CDMO as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 14 Avid Bioservices, Inc. Common Stock shares in Q1 2016.
  • Crosspoint Capital Strategies first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2015 and held it in 1 quarter.
  • Crosspoint Capital Strategies's Avid Bioservices, Inc. Common Stock position peaked at $0 in Q4 2015.
  • 84 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.